Royalty Pharma prices $1.5B senior notes offering across three tranches

Royalty Pharma plc

Issued $500M 5.150% Senior Notes due 2029, $500M 5.400% due 2034, and $500M 5.900% due 2054.
Notes are senior unsecured and guaranteed by Royalty Pharma Holdings Ltd.
Offering expected to close on June 10, 2024, subject to customary conditions.
Underwriting agreement with BofA, Citigroup, J.P. Morgan, Morgan Stanley, and TD Securities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.